Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank17
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Latest
-72.11%
↓ 102% vs avg
Percentile
P17
Within normal range
Streak
3 qtr
Consecutive declineDecelerating
Average
4720.69%
Historical baseline
PeriodValue
Q4 2025-72.11%
Q3 20257.06%
Q2 2025309.88%
Q1 20251173.31%
Q4 202487.32%
Q3 2024-147.81%
Q2 202472.43%
Q1 2024114.47%
Q4 2023-770.24%
Q3 20235926.09%
Q2 2023248.39%
Q1 202398.97%
Q4 2022-137.07%
Q3 2022163160.00%
Q2 2022-103.27%
Q1 2022176.50%
Q4 2021-80.18%
Q3 2021-18.09%
Q2 2021-100.78%
Q1 20210.00%
Q4 20200.00%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%
Q4 20190.00%
Q3 20190.00%
Q2 20190.00%
Q1 20190.00%
Q4 20180.00%
Q3 20180.00%
Q2 20180.00%
Q1 20180.00%
Q4 20170.00%
Q3 20170.00%
Q2 20170.00%
Q1 20170.00%